SCHEMBL7497329

SCHEMBL7497329

CCOC(=O)COc1cccc2c1CCC[C@@H]2OCc1nc(-c2ccccc2)c(-c2ccccc2)o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 1/20 0.49
PPARD Q03181 7/20 0.43
KDM4E B2RXH2 4/20 0.42
HPGD P15428 3/20 0.42
ALDH1A1 P00352 2/20 0.42
PPARA Q07869 1/20 0.40
NR4A2 P43354 5/20 0.39
KMT2A Q03164 3/20 0.38
NR4A1 P22736 2/20 0.38
NR4A3 Q92570 2/20 0.38
MEN1 O00255 2/20 0.37
NPY1R P25929 1/20 0.37
NPY2R P49146 1/20 0.37
CYP1A2 P05177 1/20 0.37
CYP3A4 P08684 1/20 0.37
CYP2C9 P11712 1/20 0.37
CYP2C19 P33261 1/20 0.37
RXRA P19793 2/20 0.37
RXRB P28702 2/20 0.37
GAA P10253 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7498903 1.00 PTGIR (0.49) PTGIRPPARDKDM4EHPGDALDH1A1
SCHEMBL7490763 0.90 PTGIR (0.53) PTGIRPPARDKDM4EHPGDPPARA
SCHEMBL7494627 0.90 PTGIR (0.53) PTGIRPPARDKDM4EHPGDPPARA
SCHEMBL7494535 0.85 PTGIR (0.49) PTGIRPPARDKDM4EHPGDALDH1A1
SCHEMBL7488605 0.85 PTGIR (0.49) PTGIRPPARDKDM4EHPGDALDH1A1
SCHEMBL7487220 0.82 PTGIR (0.45) PTGIRPPARDKDM4EHPGDALDH1A1
SCHEMBL7494415 0.81 PTGIR (0.45) PTGIRPPARDKDM4EHPGDALDH1A1
SCHEMBL7492835 0.81 PTGIR (0.44) PTGIRPPARDKDM4EHPGDALDH1A1
SCHEMBL7491833 0.80 PTGIR (0.43) PTGIRPPARDKDM4EHPGDALDH1A1
SCHEMBL7492994 0.80 PTGIR (0.44) PTGIRPPARDKDM4EHPGDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed